Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
“Before we examined the data, I thought we would find an ample amount of the symptoms to be specifically associated with long COVID, but that wasn’t the case," one researcher said.
The model augmented and significantly improved diagnostic performance for abdominal subspecialists as well as residents—a result researchers say has major clinical implications.
Radiomics features could be especially useful for determining TSS in scenarios where clinical data is lacking or unreliable, such as when patients have altered mental status.